Composition
- Active ingredients
- AMPICILLIN SODIUM EQ 2GM BASE/VIAL; SULBACTAM SODIUM EQ 1GM BASE/VIAL
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- AMPICILLIN SODIUM EQ 10GM BASE/VIAL; SULBACTAM SODIUM EQ 5GM BASE/VIAL · InjectableNDA050608-005 · Prescription
- AMPICILLIN SODIUM EQ 500MG BASE/VIAL; SULBACTAM SODIUM EQ 250MG BASE/VIAL · InjectableNDA050608-003 · Discontinued
- AMPICILLIN SODIUM EQ 2GM BASE/VIAL; SULBACTAM SODIUM EQ 1GM BASE/VIAL · InjectableNDA050608-001 · Prescription
- AMPICILLIN SODIUM EQ 1GM BASE/VIAL; SULBACTAM SODIUM EQ 500MG BASE/VIAL · InjectableNDA050608-002 · Prescription
- AMPICILLIN SODIUM EQ 1GM BASE/VIAL; SULBACTAM SODIUM EQ 500MG BASE/VIAL · InjectableANDA062901-001 · Discontinued
- AMPICILLIN SODIUM EQ 2GM BASE/VIAL; SULBACTAM SODIUM EQ 1GM BASE/VIAL · InjectableThis page
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA062901.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Unasyn
- Active substance
- ampicillin sodium
- Route
- Injection
- Dosage form
- Injectable
- Applicant
- Pfizer
- Status
- Discontinued
- FDA approval
- 25 Nov 1988
- Application
- ANDA062901-002